Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_assertion type Assertion NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_head.
- NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_provenance.
- NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_assertion evidence source_evidence_literature NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_provenance.
- NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_assertion SIO_000772 20298673 NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_provenance.
- NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_assertion wasDerivedFrom befree-20150227 NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_provenance.
- NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_assertion wasGeneratedBy ECO_0000203 NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_provenance.